Business Context and Reporting Period
Data Storage Corporation (DTST) filed this Form 8-K on January 12, 2024, reporting events occurring between January 5 and January 18, 2024. The filing addresses a governance issue stemming from the passing of Director Joseph B. Hoffman and provides details regarding the upcoming 2024 Annual Meeting of Stockholders.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance and listing compliance matters.
Material Changes
- Audit Committee Composition: Following the death of Mr. Joseph B. Hoffman, the Audit Committee was reduced to two members, falling below the Nasdaq requirement of three members under Rule 5605(c)(2)(A).
- Listing Status: Nasdaq notified the Company on January 18, 2024, that it is non-compliant with audit committee listing standards.
- Annual Meeting Schedule: The 2024 Annual Meeting is scheduled for June 20, 2024, with a record date of April 23, 2024.
Guidance, Outlook, and Risks
Compliance Timeline: Nasdaq has granted a cure period to regain compliance. The Company must provide evidence of compliance by the earlier of its next annual meeting or December 30, 2024. Given the June 20, 2024, meeting date, the deadline to submit compliance documentation is June 27, 2024.
Delisting Risk: If the Company fails to regain compliance by June 27, 2024, Nasdaq rules require notification of delisting. The Company may appeal such a determination to a Hearings Panel.
Management Action: The Board intends to fill the vacancy on the Board and Audit Committee within the next few weeks, ensuring the new member meets independence criteria.
Shareholder Proposals: Due to the change in the annual meeting date, the deadline for submitting stockholder proposals under Rule 14a-8 and director nominations is April 1, 2024. Notices for universal proxy solicitations are due by April 21, 2024.
Key Facts for Investor Verification
- Verify the appointment of a new independent director to the Audit Committee before the June 27, 2024, deadline.
- Monitor the Company's status regarding Nasdaq delisting notifications if the cure period expires without compliance.
- Note the April 1, 2024, deadline for submitting stockholder proposals and director nominations for the June 20, 2024, Annual Meeting.
- Confirm the final time and location of the Annual Meeting once the definitive proxy statement is filed.